Jeffrey Gregory

Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Philip J. Rosenfeld, Pravin U. Dugel, Frank G. Holz et al. · Ophthalmology · 2018 · 122 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

Lee Shapiro, David Fiorentino, Murray Baron et al. · Arthritis & Rheumatism · 2009 · 110 citations

Medicine, Pharmacology, Pharmacotherapy +13

A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Laura K. Hummers, Carin E. Dugowson, Frederick J. Dechow et al. · Annals of the Rheumatic Diseases · 2012 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study

Ryo Kubota, Chirag Jhaveri, John M Koester et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2020 · 18 citations · Full text

Medicine, Ophthalmology, Pharmacology +17